4V2-23025-39611

2 vaccinations 6 coded responses 25 check-ins 6 free-text entries 1 call case

Sex: —
Age at first dose: 31-35
ZIP prefix: 074 / NJ
Registered: 2021-04-06

Relationship: Self
Race: N/A
Ethnicity: N/A

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-06
Registered in v-safe
2021-04-06
Dose 1 — Pfizer-BioNTech
2021-04-06
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-04-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Abdominal pain

Adult check-in
2021-04-08
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache

Adult check-in
2021-04-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Rash, not including the immediate area around the injection site

Adult check-in
2021-04-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-04-11
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Rash, not including the immediate area around the injection site

Adult check-in
2021-04-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Joint pains, Rash, not including the immediate area around the injection site

Adult check-in
2021-04-13
Health check-in — day 7, dose 1
Feeling: Fair · Headache, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site

Adult check-in
2021-04-20
Survey response — day 14, dose 1
MedDRA: Fatigue, Paranoia, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities

Free text: Paranoia and metabolic water retention/ extreme stress (due to remission treatments from schizoaffective disorder and maintained abstinence from bulimia nervosa).

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-27
Dose 2 — Pfizer-BioNTech
2021-04-27
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-28
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work

Adult check-in
2021-04-29
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-05-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-05-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Joint pains

Adult check-in
2021-05-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Muscle or body aches

Adult check-in
2021-05-04
Health check-in — day 7, dose 2
Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work or attend school

Adult check-in
2021-05-11
Survey response — day 14, dose 2
MedDRA: Sinusitis — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Developed a sinus infection as of Thursday/Friday, May 7.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-18
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-25
Survey response — day 28, dose 2
MedDRA: Constipation, Paranasal sinus discomfort, Sinus congestion — Feeling: Fair

Free text: Some sinus pressure and congestion. Some constipation.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-01
Survey response — day 35, dose 2
MedDRA: Hallucination, auditory, Headache, Paranoia — Feeling: Poor · Be unable to work

Free text: Paranoia, auditory hallucinations;Headache

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-08
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-27
Survey response — 3 months, dose 2
MedDRA: Adverse drug reaction, Panic attack, Paranoia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Panic attack/paranoia from a new psychiatric medication (it was then cancelled).

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-10-26
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-04-27
Survey response — 12 months, dose 2
MedDRA: Dissociation — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization

Free text: Psychiatric dissociation, trialed a new psych medication inpatient.

MedDRA releases: 2024-11 · check-in free text available
2022-04-27
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-04-29
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-06	Pfizer-BioNTech
2	2021-04-27	Pfizer-BioNTech

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 7 — day 14, dose 1

2021-04-20

Symptoms: Paranoia and metabolic water retention/ extreme stress (due to remission treatments from schizoaffective disorder and maintained abstinence from bulimia nervosa).

Release 8 — day 14, dose 2

2021-05-11

Symptoms: Developed a sinus infection as of Thursday/Friday, May 7.

Release 8 — day 28, dose 2

2021-05-25

Symptoms: Some sinus pressure and congestion. Some constipation.

Release 8 — day 35, dose 2

2021-06-01

Symptoms: Paranoia, auditory hallucinations;Headache

Release 9 — 3 months, dose 2

2021-07-27

Symptoms: Panic attack/paranoia from a new psychiatric medication (it was then cancelled).

Release 11 — 12 months, dose 2

2022-04-27

Symptoms: Psychiatric dissociation, trialed a new psych medication inpatient.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Adverse drug reaction	✓	·	✓
SD	Constipation	✓	✓	✓
SD	Dissociation	·	·	✓
SD	Fatigue	✓	✓	✓
SD	Hallucination, auditory	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Panic attack	✓	·	✓
SD	Paranasal sinus discomfort	✓	✓	✓
SD	Paranoia	✓	✓	✓
SD	Pre-existing disease	✓	✓	✓
SD	Sinus congestion	✓	✓	✓
SD	Sinusitis	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release